IL2 and Miyoshi myopathy: However, approximately 50% of untreated MM patients showed Vδ2 T cells that were unable to proliferate upon stimulation with zoledronate and IL-2, but had strong effector properties exhibiting TEM or TEMRA phenotypes (42, 43).